Hinge Health, Inc. (HNGE) shares surged 5.03% during intraday trading on Tuesday, as investors reacted positively to a wave of bullish analyst coverage from major Wall Street firms.
The rally came after Evercore ISI analyst Elizabeth Anderson CFA maintained a Buy rating on Hinge Health Class A stock, alongside a reiterated Buy rating from Morgan Stanley analyst Craig Hettenbach. Both firms reaffirmed their positive outlook on the digital musculoskeletal care provider, signaling continued confidence in the company's growth trajectory and market position.
The dual endorsements from two prominent investment banks appeared to boost investor sentiment, driving the stock significantly higher during the session as market participants digested the favorable analyst commentary.